PRICE T ROWE ASSOCIATES INC /MD/ - TRACON PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 46 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$113,000
-38.6%
17,400
-22.3%
0.00%–
Q1 2021$184,000
+12.9%
22,400
+61.2%
0.00%–
Q4 2020$163,000–13,900–0.00%–
 Download
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,764,508$1,386,4720.33%
Ikarian Capital, LLC 2,765,530$804,7690.13%
JOHNSON & JOHNSON 84,003$24,4450.01%
BOOTHBAY FUND MANAGEMENT, LLC 258,844$75,3240.00%
Virtu Financial LLC 28,362$80.00%
LINDEN ADVISORS LP 454,916$132,3810.00%
BlackRock Inc. 267,719$77,9060.00%
Bank of New York Mellon Corp 10,259$2,9850.00%
HRT FINANCIAL LP 49,165$140.00%
MGO ONE SEVEN LLC 11,780$3,4280.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders